GenomiCare Biotechnology provides pharmaceutical and biotech companies with real world insights into key differences in disease mechanism and cancer treatment in China.

Our solutions are explicitly designed to be flexible and customized to meet the unique needs of each organization and each programs. Our patient-centric and sponsor-directed prospective cohort expansion capability offer companies a powerful new way to understand the real-world care and unique treatment modalities for cancer patients in China.